The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.

The Office of Financial Aid and Scholarships is working on exciting new scholarship opportunities for new freshman. Please continue to check our website for scholarship announcements no later than ...